BORDEAUX, France, November 26, 2014 /PRNewswire/ --
- Reminder on the terms for exercising redeemable share
purchase warrants (BSAR)
- Laurence Géricot joins the Europlasma Group as Chief
Financial Officer
- Europlasma has joined the EnterNext PEA-PME 150
index
Europlasma, a French manufacturer with
international reach, designing and
using plasma solutions to produce renewable energy and
recover hazardous waste, reminds the terms for exercising the
redeemable share purchase warrants (BSAR) issued by the company on
6 November 2014, announces the
appointment of a new Chief Financial Officer, and announces that
the Europlasma Group has joined the EnterNext PEA-PME 150
index.
- Reminder on the characteristics of and terms for exercising
redeemable share purchase warrants (BSAR)
Following the capital increase launched on 24 September 2014, the company issued and granted
to each shareholder two classes of BSAR warrants listed on
Alternext Euronext Paris.
Characteristics:
BSAR A (ISIN FR0012160653): Two BSAR A warrants entitle
holders to subscribe for one new share at €0.80 per share, for a
period of three years from 6 November
2014.
BSAR B (ISIN FR0012160661): Four BSAR B warrants entitle holders
to subscribe for one new share at €1.30 per share, for a period of
five years from 6 November 2014.
Subscribing for new shares through the exercise of BSAR warrants
entitles the holder to an ISF (French solidarity tax on wealth)
reduction of up to 50% of the invested amount. This reduction is
capped at €45,000 and subject to French tax regulations.
Terms of exercise:
In order to exercise their BSAR, holders should send their
subscription instructions with payment of the corresponding
exercise price to their intermediary custodian.
Caceis Corporate Trust, will ensure the centralisation and
execution of these operations within two working days.
The new shares resulting from the exercise of BSAR A and BSAR B
will be subject to periodic requests for admission to trading on
Alternext Euronext Paris and will be listed under the same ISIN
code as existing shares of the company, i.e. FR0000044810.
- Appointment of Laurence Géricot as Chief Financial
Officer
Laurence Géricot has been newly appointed as the Group's Chief
Financial Officer by the Europlasma Board of Directors to replace
Estelle Mothay, who decided to give new impetus to her career. The
Board of Directors thanks Estelle for her contribution and
commitment over the last four years.
Laurence began her career at Hewlett Packard in 1988 with
various high-level operational and financial positions in
France and abroad (including three
years at the head office in California).
In 2006, she joined the field of biotechnologies as Deputy CEO
responsible for the finances of Biomedical Diagnostic. From 2010 to
2014, she completed several operations in finance, management and
consulting for innovative companies (including Nanobiotix listed on
Euronext Paris) before joining the Europlasma Group. Laurence is a
graduate from ESSEC Business School (MBA Grande Ecole).
- Europlasma joins the EnterNext PEA-PME 150
index
Europlasma has been included in the PEA-PME 150 index, which
comprises 150 PEA-eligible French companies listed on the Euronext
or Alternext markets in Paris.
This new index represents a benchmark for investors, with 150
listed companies across all sectors and forming part of 80% of the
most liquid PEA-PME eligible assets.
Jean-Eric Petit made the
following statement: "Joining a benchmark index should increase our
visibility among French and foreign investors and develop the
liquidity of our shares, although they have accelerated over the
last few days, no doubt as a result of our latest capital increase.
During the trading session of 13 November
2014, 24,575,980 shares (i.e. 36% of capital) were traded,
thereby showing the strong interest of investors in the Group's
shares. It should be noted that no threshold crossing was declared
to the company within the statutory period of five trading days
from the session."
About Europlasma
Europlasma, the French company with a global reach that designs,
builds and operates plasma solutions for renewable energy
generation and hazardous waste recovery. Founded in 1992 to apply
its proprietary plasma torch technology to hazardous waste
destruction, it is now built on the following three business
units:
- Europlasma is in charge of developing, constructing and
operating various industrial processes using plasma
technology;
- CHO Power is a supplier and operator of waste and
biomass power plants by advanced gasification;
- Inertam is the global specialist in the destruction and
recycling of asbestos and hazardous waste.
http://www.europlasma.com [Alternext - NYSE Euronext Paris
- Mnemo : ALEUP - Isin : FR0000044810]
EUROPLASMA
Jean- Éric PETIT - CEO
Laurence GÉRICOT - CFO
Anne BORDERES - Shareholders & investors
contact
Tel: +33(0)556-497-000 / contactbourse@europlasma.com